<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 364 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page363.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=364">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 364 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 364</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=364"><img src="../thumb/364.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Immunological - 24.1                                                           2020-04 / 327
       Dosage: Do not crush tabs. Ren.reject.prophylax: Adults: Init.  Herpes Simpl., leg cramps, myalg., myasthen., arthralg., hyperton.,   infects., allerg./anaphylact.reacts., poss.synergist. /addit. nephrotox.
       dos.to be admin. with.72 hrs. of transplant. Recomm.dos: 1 g 2xdly.  haematur., ren. tubul.necros., UTI, albuminur., hydronephros., pyelo-  effs., hypo-/ hyperkalaemia, pre-exist. infect.dis.aggravat., gen.& loc.
       Card.reject.prophylax: Adults: 1,5 g 2xdly start. within 5 days   nephrit., dysur., urin.freq./incontin./retent., oligur., noctur., asthen.,   infects., BK virus assoc.nephropathy, JC virus assoc.progress. mul-
       of card.transplant.           fev., headache, infect., pain incl.abdom./back/chest/pelv., periph.  tifoc. leukoencephalopathy (PML), lymphoma, lymphadenopathy,
       Hepat.reject.prophylax: Adults: 1,5 g 2xdly. Init. ASAP aft.  oed., sepsis, cysts, enlarg.abdom., fac.oed., flu syndr., haemorrh.,   malign., benign & malign. neoplasms, skin.malign., ischaem.coron.
       transplant.                   malaise, hernia, ascit.      art. disords., tachycard., ventric.dysrhythm., card. arrest, heart fail.,
       Contraindications: Pregn.& lactat., safety & effic. in childr.not est.  Warnings and special precautions: Ther.not to be init. until neg.  cardiomyopath., ventric. hypertroph., supraventric.dysrhythm., palpit.,
       for card./ hepat.reject. prophylax., no data avail.for card./hepat.trans-  pregn.test acquir., dr.to be alert. should pregn.occur, effect.contracept.  abnorm. ECG/heart rate, pericard.effus., abnorm. echocardiog., bld.
       pl. pts. with sev.chron. ren.impairm., no data avail.for card. transpl.  advis. bef. init. ther./dur./6 wks.aft.ther.discont., incr. lymphomas & oth-  dyscras., trem., headach., seiz., disturb. consciousn., paraesthes.&
       pts.with sev.hepat.parenchym.dis., limit. data for hepat.transpl.pts.  er malign.partic.of skin develop., limit. sun/UV light expos., incr.suscept   dysaesthes., periph. neuropath., dizzin., imp.writing, CNS disord,
       with concom. tacrolimus.      to infect. incl. opportunist./fatal infect.& sepsis, monit.for neutropen.,   coma, CNS haemorrh. & CVA, paralys.& pares., encephalopath.,
                                                st
                                                           rd
                                                         nd
       Side effects: Incr.GI adverse effs.incl.candidias., sepsis, UTI, her-  compl.bld.counts wkly.dur.1  month, twice month.2  & 3  month then   speech/lang.abnormalit., amnes., hyperton., myasthen., blurr.vis.,
                                            st
       pes simplex/zoster, pneum., flu, RTI, resp.tract monilias., infect.,   once/mnth.dur.1  yr., discont.ther.if. severe neutropenia devel., pts. to   photophob., eye disords., cataract, blindn., tinnit., hypoacus., neuro-
       bronchit./ pharyngit., sinusit., fung.skin infect./candida, vag. can-  report any evid.of infect./unexpect.bruis./ bleed., incr.risk of activat.of   sens.deafn., imp.hear., dyspn., parenchym. lung disords., pleur.effus.,
       didias., rhinit., meningit., endocardit., TB, atyp. mycobact. infect.,   latent vir.infects, avoid live attenuat.vacc.use, intra-uter.devices, act.   pharyngit., cough, nas.congest./inflammat., resp.fail., resp. tract dis-
       skin Ca, benign skin neoplasm, cysts incl. lympho-& hydrocele, bld.  ser.digest.syst.dis.due to report.GI ulcerat./ haemorrh. & perforat.,   ords., asthma, ac.resp.distress syndr., diarrh., nausea, GI inflammat.
       dyscras., ecchymos., polycythaem., bone marrow depress., red cell   avoid in rare heredit.defic. of hypoxanthine-guanine phosphoribosyl-  condits, GI ulcerat./ perforat/haemorrh., stomatit., ulcerat., ascit.,
       aplas., abnorm.neutroph.morphol., hypersens./ anaphylact.reacts.,   transferase, ren.transpl.with sev.chron.ren. impairm., elderly, concom.  vomit., GI/abdom. pain., dyspeps., constip., flatul., bloat./ distens.,
       angioed., diab. mellit., Cushing syndr., parathyroid disord., electrol./   azathioprine./ cholestyramine not recomm., monit.concom. aciclovir/   paralyt.ileus, peritonit., pancreatit., incr.bld. amylase, GORD, imp.
       bld.lipid disturbs.incl. hypercholesterolaem., hyperglycaem., hyper-  valaciclovir/ganciclovir/valganciclovir in pres. of ren.funct.impairm.,   gastr. empt., sub ileus, pancreat.pseudocyst, ren. impairm/ fail., oligur.,
       kalaem., hypokalaem., hypomagnesaem., hypocalcaem., hyperlipi-  teratogen.effs.in rats & rabbits, consid.addit.birth contr.meth.as effect   ren.tubul.necros., tox. nephropathy, urin.abnormalit., bladd./urethr.
       daem., hypophosphataem., hyperuricaem., gout, acidos., dehydrat.,   of OC’s poss.reduc., sev.chron.ren.impairm.outside of immed. post-op   sympts., anur., haemolyt.uraem.syndr., haemorrh. cystit., prurit., rash,
       weight gain, psych.disords., CNS effs., trem., convuls., dizzin., my-  per., monit.with concom. tacrolimus./ rifampicin  alopec., acne, incr.sweat., dermatit., photosens., tox.epiderm.necro-
       asthen.syndr., headache, hyperton., paraesthes., somnol., eye dis-  Interactions: Incr.plasma conc.of both meds. when admin.concom.  lys., Stev. Johns. syndr, arthralg., musc.cramp., limb/back pain, joint
       ords., conjunctivit., deafn., tinnit., tachycard., ang.pect., dysrhythm.,   with acyclovir./valaciclovir/ ganciclovir/valganciclovir, drugs known to   disords., hirsut., hyperglycaem.condits., diabet. mellit., hyperkalaem.,
       atrial fibrillat., card.arrest, CHF, ventr.extrasystol., hyper-/ hypotens.,   undergo ren. tubul.secret.may raise plasma conc.of either drug, decr.  hypomagnesaem., hypophosphataem., hypokalaem., hypocalcaem.,
       vasodilat., syncope, dyspn, incr. cough, pneum., pleur.effus., asthma,   plasma conc.with cholestyramine, absorpt. decr.with antacids., po-  hyponatraem., fluid overload., hyperuricaem., decr. appetit., anorex.,
       pulm. oed., interstit. lung dis., pulm.fibros., pancreatit., peritonit., GI   tent.bone marrow suppress. with concom.azathiopine, decr. levonorg-  metabol.acidos., hyperlipidaem., hypercholesterolaem., hypertriglyc-
       haemorrh., gingivit., gum hyperplas., stomatit., intest.villous atrophy,   estrol AUC, poss.incr.plasma conc.of metabol. with probenecid, anti-  eridaem., dehydrat., hypoproteinaem., hyperphosphataem., hypogly-
       jaund., hyperbilirubinaem., hepatit., skin disords., alopec., hirsutism,   bod.respons.to vacc. poss.dimin., plasma AUC chang.with tacrolimus.,   caem., hypertens., haemorrh., thrombembol/ ischaem.events, periph.
       skin hypertrophy, leg cramps, myalg., arthralg., myasthen., haematur.,   decr. expos.with concom. rifampicin, norfloxacin/ metronidazole/ cip-  vasc. disords., vasc.hypotens.disords., infarct., deep limb ven. throm-
       dysur., urin.freq./ incont./ retent., asthen., fev., chills, abdom./back/   rofloxacin/amoxicillin & clavulanic acid.reduc.mycophenolic acid AUC  bos., shock, asthen.condits., febril. disords., oed., pain/discomf., incr.
       chest/pelv./neck pain, oed.   MYFORTIC, Novartis [P/S]     bld.alkal. phosphat., incr./decr.weight, disturb.body temp. percept.,
       Special precautions: Ther.not to be init.until neg. pregn.test ac-  Mycophenolic acid  multi-org.fail., influenz.like illn., temp. intol., chest press.sensat., jit-
       quir., dr.to be alert.should pregn. occur, effect. contracept.advis.   Indications: Combin.with ciclosporin for micro-emuls.& corticoster.  ter., incr.bld. lactat. dehydrogen, thirst, fall, chest tightn., decr. mo-
       bef.init.ther./dur. /6 wks.aft.ther. discont., incr.lymphomas & other   for prevent.ac.transplant reject. in adult allogeneic ren.transplants.  bilit., incr.fat tis., hepat.enzym./funct. abnormalit., cholestas./jaund.,
       malign.partic.of skin develop., limit.sun/UV light expos., incr.sus-  (S4) TABS, 37/34/0158,0159  hepatocell. damage/ hepatit, cholangit., hepatit. art. thrombos., veno
       cept to infect.incl.opportunist./fatal infect.& sepsis, monit.for neu-  705493-001: 180 mg, 120, R2 770,88  occlus.liv.dis., hepat.fail., bile duct stenos., dysmenorrh., uterin.bleed.,
                        st
       tropen., reg.compl. bld. counts wkly.dur.1  month, twice month.2   nd  705492-001: 360 mg, 120, R5 541,75  insomn., anx., confus./disorientat., depress., mood disords., nightmar.,
                      st
       & 3  month then once/mnth.dur.1  yr., interrupt./ discont. ther.if   Dosage: Admin by qualified transplant special. Do not crush tab.   hallucinat., ment./psychot.disords., IV infus. incompat.with PVC plast.
         rd
       absol.neutrophil count is &lt;1,3x10 / µL, pts.to report any evid.of in-  Avoid inhalat./direct contact with skin/muc.membr.of powd.if tabs.ac-  Special precautions: Prolong.releas.tacrolim. formulat. not inter-
                     3
       fect./unexpect. bruis./ bleed., avoid live attenuat.vacc.use except   cident.brok. Init.in de-novo pts.within 48 hrs.foll.transplant. Recomm.  chang.with immediat.releas. formulat. without supervis.of transpl.
       influenza vacc., act.ser.digest.syst.dis.due to report. GI ulcerat./  dos: 720 mg 2xdly (1440 mg dly dos.)  special., cross. the placenta, contracept.other than OC’s, decr. tac-
       haemorrh.& perforat., avoid in rare heredit.defic.of hypoxanthine-  Contraindications: Pregn.& lactat., safety & effic.in childr.not   rolimus levels during diarrh.epis., allergy., MRI should be perform.
       guanine phosphoribosyl-transferase, ren.transpl.with sev. chron.   est., concom.azathioprine, live vaccin., other immunosuppress.  if pts.present.with PRES, pts. with diagn.or suspect.congen.long
       ren.impairm., elderly, concom.azathioprine./ cholestyramine not   use not stud.  QT syndr., adeq. BP contr. & immed.discont.of system. tracrolimus
       recomm., monit.concom. aciclovir/ valaciclovir/ganciclovir/valgan-  Side effects: Leucopen., diarrh., lymphoma & other malign.de-  if PRES diagn., ascert.EBV serolog.bef. treatm. in childr.&lt;2 yrs., vis./
       ciclovir in pres. of ren.funct.impairm., teratogen.effs.in rats & rab-  velopm., opportunist./fatal infects. /infestat., URTI, wound infect.,   neurologic.disturbs., pts. who have prev.receiv.polyoxyethelat.castor
       bits, sev.chron.ren.impairm.outside of immed. post-op per., monit.  sepsis, osteomyelit., bld.dyscras., lymphat.syst.disords., headache,   oil contain. preps./ciclosporin, vaccinat.less effect., avoid live attent.
       with concom.tacrolimus.       tremor, insomn., cough, pulm.congest., wheez., GI disords.incl.per-  vacc., meds.with nephrotox.effs., high K  intake/K spar.diuret., avoid
                                                                                   +
                                                                                       +
       Drug interactions: Incr.plasma conc.of both meds. when admin.  forat.& haemorrh./ peritonit., gingiv.hyperplas., fatig., pyrex., flu.like   mix.with other drugs., teratogen.at dos.that also demonstr. maternal
       concom.with acyclovir./ valaciclovir/ ganciclovir/valganciclovir, drugs   illn., low.limb oed., pain, rigors, thirst, weakn., hyperlipidaem., diab.  toxic., excret.into breast milk, other immunosuppress. ther., incr.sus-
       known to undergo ren.tubul.secret.may raise plasma conc.of either   mellit., hypercholesterolem., hypophosphataem., alopec., contus., ab-  cept.to vir./bact./ fung. & protozoal infects., imp.liv./kidn.funct., for
       drug, decr.plasma conc.with cholestyramine, absorpt.decr.with ant-  norm. hepat. funct.tests, tachycard., pulm.oed., ventric. extrasystol.,   details concern.pt.monit.by special physic.refer.to prod.lit.
       acids., potent. bone marrow suppress.with concom. azathiopine,   conjunctivit., blurr.vis., arthritis, back pain, musc.cramps, skin papil-  Drug interactions: Vis./neurological disturbs. effs. enhanc.with
       decr.levonorgestrol AUC, poss.incr. plasma conc.of metabol.with   loma, bas.& squam. cell Ca, Kaposi’s sarcoma, lymphoproliferat. dis-  concom.alcoh., incr./decr. plasma lev.with methylprednisolone, incr.
       probenecid, antibod. respons. to other vacc.dimin.with concom.live   ords., abnorm.dreams, delus.percept., haematur., ren.tubul.necros.,   whole bld./ plasma lev.with imidazole antimycot./ macrolide antibiot./
       vacc., plasma AUC chang.with tacrolimus.  urethral strict., impot., incr.bld.creatin., pancreatit., pure red cell aplas.  nifedipine/nicardipine/HIV protease inhibits./danazol/omeprazole/
       MYCOPHENOLATE ALKEM, (Activo) Alkem [P/S]  Special precautions: Teratogen.in anim., negat. pregn.test   ethinylestradiol & Ca antagon., enhanc. nephrotoxic.with ampho-
                                                                  tericin-B/ibuprofen, decr. bld. lev.with rifampicin/ phenytoin/ pheno-
       Mycophenolate mofetil         recomm.bef.init.ther., use effect. contracept. bef./dur.& x6 wks.aft.  barbital & St.John’s Wort, bld.lev.of phenytoin.incr., decr. clear.& incr.
       Indications: Organ reject.prophylax.in allogeneic ren./hepat.or card.  discont.ther., sev. chron.ren.impairm., avoid in rare heredit.defic. of   half-life of pentobarbital/antipyrine, ciclosporin half life incr., inhib.
       transplants concom.with cyclosporin & corticoster.  hypoxanthine-guanine phosphoribosyl-transferase, immunosuppress.  eff.on cytochrome P-450 3A4, bromocriptine, cortisone, dapsone, er-
       (S4) CAPS, 45/32.2/0219       incr.suscept.to lymphoma & other malign.developm.esp.of skin, limit.  gotamine, ethinylestradiol, gestodene, itraconazole, josamycin, ligno-
       720271-001, 250 mg, 100, R1 146,17  UV/sun expos., report any evid.of infect./ unexpect. bruis./bleed/  caine, mephenytoin, miconazole, midazolam, nicardipine, nifedipine,
       (S4) TABS, 45/32.2/0220       bone marr.depress. manifestat, oversupress.of immune system., reg.   nilvadipine, norethindrone, quinidine, tamoxifen, triacetyloleandro-
                                     complete bld.counts dur.1st yr., consid.progress. multifoc. leukoen-
       720272-001, 500 mg, 50, R1 146,17                          mycin, verapamil inhib.metabol., naringenine( flavenoid.in grapefruit
       Dosage: Take on empty stomach, do not open cap/crush tabs.  cephalopath.as diff.diagn.in immunosuppress.pts.report.neurolog.  juice) inhib. cytochrome P-450 3A4 syst., lansopraz/ciclospor. inhibit.
                                     sympts., consid. polyomavir.assoc.nephropath.as diff.diagn. in im-
       Ren.reject.prophylax: Adults: Init.dos.to be admin. within 72 hrs.  CYP3A4-mediat.metabol., poss.decr.lev. with barbits., phenytoin,
       of transplant. Recomm.dos: 1 g 2xdly.  munosuppress.pts.with deteriorat.ren.funct., interrupt./reduc.dos.if   rifampicin, carbamazepine, metamizole & isoniazid, induc.of cyto-
                                     absolute neutrophil count is &lt;1,5x10 /µL, avoid live attenuat.vacc.
                                                    3
       Card.reject.prophylax: Adults: 1,5 g 2xdly start. within 5 days   chrome P-450 3A4 syst., inhib.cortisone & testosterone metabol.,
       of card.transplant.           use, ser.act. digest. syst. dis., concom aciclovir/Mg & Al antacids/   decr.effic.OC’s, other plasma prot.bind.meds.e.g.oral anticaogs./
                                     cholestyramine /tacrolimus & ganciclovir.
       Hepat.reject.prophylax: Adults: 1,5 g 2xdly. Init. ASAP aft.  antidiabets., enhanc.neurotox.of ganciclovir/ aciclovir, meal of mod.
       transplant.                   Drug interactions: Plasma lev.of mycophenol. acid & acyclo-  fat cont.reduc.bioavail. /absorpt.signific., poss.incr.risk of over-immu-
       Contraindications: Pregn.& lactat., safety & effic. in childr.not est.  vir incr., absorpt.decr.with antacids., system. expos.reduc.with   nosuppress. if given tog.with other potent immunosuppress. meds.,
                                     cholestyramine, OC effic. poss. advers.affect., antibody respon.to
       for card./hepat.reject. prophylax., no data avail.for card./hepat.trans-  disintegrat.with meds. exhib. alkal.reacts.in sol.
       pl. pts. with sev.chron.ren.impairm., no data avail.for card. transpl.  other vacc, diminish.  See also MDR page 211.
       pts.with sev.hepat.parenchym.dis., limit. data for hepat.transpl.pts.  PROGRAF, Astellas [P/S] &
       with concom. tacrolimus.      Tacrolimus                   RAPAMUNE, Pfizer [P/S] &
       Side effects: Meningit., infect.endocardit., anaem., leukocytos.,   Indications: Prim.immunosuppress.in.liv./ kidn allograft recipi-  Sirolimus
       leukopen., thrombocytopen., ecchymos., polycythaem., incr.pro-  ent and liv./kidn or heart allograft reject.resist.to convent.immu-  Indications: Prophylax.of organ reject.in ren. transplant.init.in combi-
       thrombin time/ INR, incr. thromboplastin time, aplast.anaem., bone   nosuppress.regim.  nat.with cyclosporin & corticoster. Consid.cyclospor.withdr.2-4 mnths.
       marr.depress., pure red cell aplasia., diabet. mellit., parathyr.disord.,   (S4) IV INFUS, [P/S] 32/34/0561. 5 mg/ml  Aft transpl.in pts.with low immunolog.graft loss risk.
       Cushing’s syndr., hypercholesterolaem., hyperglycaem., hyperkalaem.,   854379-003: 10x1 ml amps, R13 916,41  (S4) TABS, [P/S] 35/34/0009
       hypokalaem., hypomagnesaem., hyponatraem., hypophosphataem.,   (S4) CAPS, [P/S] A39/34/0647, 32/34/0559, 0560  700103-003: 1 mg, 30, R3 180,21
       acidos., incr. alkaline phosphat., dehydrat., hyperlipidaem., weight   713506-002: 0,5 mg, 30, R646,04  Dosage: Oral admin only. Bioavail.of tabs.not determ. if crush./
       gain, convuls., emot.labil., hallucin., neuropathy, abnorm.think., de-  713506-001: 0,5 mg, 50, R1 076,73  chew./split. Treatm.init & remain under guid.of special.physic.only.
       lir., hyperaesthes., psychos., agitat., depress., anx., insomn., trem.,   851442-006: 1 mg, 30, R1 179,99  Admin. consistent. with/without food to minim.bld.lev. variant.
       paraesthes., somnol., amblyop., abnorm.vis., conjunctivit., cataract,   851442-005: 1 mg, 100, R3 933,30  Recomm.with cyclosporin & corticoster. regimen. Admin.4 hrs.aft.
       hypertens., hypotens., ang. pect., dysrhythm., atrial fibrillat., card.  851450-009: 5 mg, 30, R5 706,16  cyclospor.microemuls.
       arrest, congest. heart fail., postur.hypotens., vasodilat., bradycard.,   851450-008: 5 mg, 50, R9 510,27  Init.ther.in combinat.with cyclosporin: Adults & childr.13 yrs &
       pericard.effus., tachycard., pneumon., sinusit., asthma, pulm.oed.,   Dosage: Refer to manufact.lit.for furth.details.  over: De novo transplant recipients: Load dos: 6 mg Maint: 2 mg dly.
       rhinit., pharyngit., bronchit., pleur.effus., dyspn., cough., TB, atypic.   Contraindications: Pregn.& lactat., polyoxyethylat. cast.oil/struct.  Maint.ther.follow.cyclospor.withdr: Discont. cyclospor.2-4 mnths
       mycobact. infect., GI disords incl.oesophagit./ stomatit./ pancreatit.,   relat.compds.(IV infus.), hypersens.  follow.transplantat.progress. over 4-8 wks.& adjust Rapamune dos
                                                                                      st
       hepatit., elev.ALT/AST, bilirubinaem., acne, alopec., benign neoplasm   Side effects: EBV-assoc.lymphoproliferat. disords., poster.revers.en-  to obt.bld. trough conc.within 16-24 ng/ml for 1  yr.follow, transplan-
       of skin, fung.dermatit., hirsut., skin carcinoma/ hypertroph./ ulc., rash,   cephalopathy syndr. (PRES)., vis./neurologic.disturbs., incr.suscept.to   tat & thereaft.target trough range is 12-20 ng/ml. (chromatograph.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page363.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page359.html">359</a>&nbsp;&nbsp;&nbsp;<a href="page360.html">360</a>&nbsp;&nbsp;&nbsp;<a href="page361.html">361</a>&nbsp;&nbsp;&nbsp;<a href="page362.html">362</a>&nbsp;&nbsp;&nbsp;<a href="page363.html">363</a>&nbsp;&nbsp;&nbsp;<a href="page364.html">364</a>&nbsp;&nbsp;&nbsp;<a href="page365.html">365</a>&nbsp;&nbsp;&nbsp;<a href="page366.html">366</a>&nbsp;&nbsp;&nbsp;<a href="page367.html">367</a>&nbsp;&nbsp;&nbsp;<a href="page368.html">368</a>&nbsp;&nbsp;&nbsp;<a href="page369.html">369</a>
             </td>
             <td width="35%"><a href="page365.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page365.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
